TFPI cofactor function of protein S: Essential role of the protein S SHBG-like domain

Blood

Volumn 123, Issue 25, 2014, Pages 3979-3987

  Reglinśka Matveyev, Natalia ^a   Andersson, Helena M ^a   Rezende, Suely M ^b   Dahlbäck, Björn ^c   Crawley, James T B ^a   Lane, David A ^a   Ahnström, Josefin ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4B BINDING PROTEIN; PROTEIN S; SEX HORMONE BINDING GLOBULIN; TISSUE FACTOR PATHWAY INHIBITOR;

ARTICLE; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN SHBG LIKE DOMAIN; SURFACE PLASMON RESONANCE;

BINDING SITES; BLOTTING, WESTERN; COMPLEMENT C4B-BINDING PROTEIN; FACTOR XA; HEK293 CELLS; HUMANS; LIPOPROTEINS; MUTATION; PHOSPHOLIPIDS; PROTEIN C; PROTEIN S; SEX HORMONE-BINDING GLOBULIN; SURFACE PLASMON RESONANCE; THROMBIN; THROMBOPLASTIN;

EID: 84902668872     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-01-551812     Document Type: Article

References (42)

1. Wun TC, Kretzmer KK, Girard TJ, Miletich JP, Broze GJ Jr. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem. 1988;263(13):6001-6004.
2. Broze GJ Jr, Girard TJ. Tissue factor pathway inhibitor: structure-function. Front Biosci (Landmark Ed). 2012;17:262-280.
3. Dahm A, Van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM. Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis. Blood. 2003;101(11):4387-4392. (Pubitemid 36857803)
4. Broze GJ Jr, Lange GW, Duffin KL, MacPhail L. Heterogeneity of plasma tissue factor pathway inhibitor. Blood Coagul Fibrinolysis. 1994;5(4):551-559. (Pubitemid 24301576)
5. Nordfang O, Bjørn SE, Valentin S, et al. The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity. Biochemistry. 1991;30(43):10371-10376.
6. Lindhout T, Willems G, Blezer R, Hemker HC. Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitor. Biochem J. 1994;297(Pt 1):131-136. (Pubitemid 24025614)
7. Wesselschmidt R, Likert K, Girard T, Wun TC, Broze GJ Jr. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa. Blood. 1992;79(8):2004-2010.
8. Huang ZF, Higuchi D, Lasky N, Broze GJ Jr. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood. 1997;90(3):944-951. (Pubitemid 27314126)
9. Aiach M, Borgel D, Gaussem P, Emmerich J, Alhenc-Gelas M, Gandrille S. Protein C and protein S deficiencies. Semin Hematol. 1997;34(3):205-216.
10. Simmonds RE, Ireland H, Lane DA, Zöller B, García de Frutos P, Dahlbäck B. Clarification of the risk for venous thrombosis associated with hereditary protein S deficiency by investigation of a large kindred with a characterized gene defect. Ann Intern Med. 1998;128(1):8-14.
11. Broze GJ Jr, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood. 1988;71(2):335-343. (Pubitemid 18089519)
12. Sanders NL, Bajaj SP, Zivelin A, Rapaport SI. Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component. Blood. 1985;66(1):204-212. (Pubitemid 15004805)
13. Girard TJ, Warren LA, Novotny WF, et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature. 1989;338(6215):518-520. (Pubitemid 19107996)
14. Huang ZF, Wun TC, Broze GJ Jr. Kinetics of factor Xa inhibition by tissue factor pathway inhibitor. J Biol Chem. 1993;268(36):26950-26955.
15. Hackeng TM, Seré KM, Tans G, Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci U S A. 2006;103(9):3106-3111. (Pubitemid 43346432)
16. Ndonwi M, Tuley EA, Broze GJ Jr. The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition. Blood. 2010;116(8):1344-1351.
17. Ahnström J, Andersson HM, Hockey V, et al. Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S. Blood. 2012;120(25):5059-5062.
18. Lundwall A, Dackowski W, Cohen E, et al. Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation. Proc Natl Acad Sci U S A. 1986;83(18):6716-6720. (Pubitemid 16002304)
19. Deutzmann R, Huber J, Schmetz KA, Oberbäumer I, Hartl L. Structural study of long arm fragments of laminin. Evidence for repetitive C-terminal sequences in the A-chain, not present in the B-chains. Eur J Biochem. 1988;177(1):35-45.
20. Joseph DR, Baker ME. Sex hormone-binding globulin, androgen-binding protein, and vitamin K-dependent protein S are homologous to laminin A, merosin, and Drosophila crumbs protein. FASEB J. 1992;6(7):2477-2481.
21. Nishioka J, Suzuki K. Inhibition of cofactor activity of protein S by a complex of protein S and C4b-binding protein. Evidence for inactive ternary complex formation between protein S, C4b-binding protein, and activated protein C. J Biol Chem. 1990;265(16):9072-9076.
22. Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem. 1986;261(26):12022-12027. (Pubitemid 17202758)
23. ten Kate MK, van der Meer J. Protein S deficiency: a clinical perspective. Haemophilia. 2008;14(6):1222-1228.
24. Nyberg P, Dahlbäck B, García de Frutos P. The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function. FEBS Lett. 1998;433(1-2):28-32.
25. Evenäs P, García de Frutos P, Nicolaes GA, Dahlbäck B. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa. Thromb Haemost. 2000;84(2):271-277.
26. Andersson HM, Arantes MJ, Crawley JT, et al. Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain. Blood. 2010;115(23):4878-4885.
27. Ahnström J, Andersson HM, Canis K, et al. Activated protein C cofactor function of protein S: a novel role for a γ-carboxyglutamic acid residue. Blood. 2011;117(24):6685-6693.
28. Saller F, Villoutreix BO, Amelot A, et al. The gamma-carboxyglutamic acid domain of anticoagulant protein S is involved in activated protein C cofactor activity, independently of phospholipid binding. Blood. 2005;105(1):122-130. (Pubitemid 40053073)
29. Lorand L, Mann KG. Proteolytic Enzymes in Coagulation, Fibrinolysis and Complement Activation. Part A, Mammalian Coagulation Factors and Inhibitors. San Diego: Academic Press; 1993.
30. Dahlbäck B, Hildebrand B, Malm J. Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies. J Biol Chem. 1990;265(14):8127-8135.
31. Norstrøm EA, Steen M, Tran S, Dahlbäck B. Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va. J Biol Chem. 2003;278(27):24904-24911. (Pubitemid 37548650)
32. Dahlbäck B, Müller-Eberhard HJ. Ultrastructure of C4b-binding protein fragments formed by limited proteolysis using chymotrypsin. J Biol Chem. 1984;259(19):11631-11634. (Pubitemid 14022071)
33. Perkins SJ, Chung LP, Reid KB. Unusual ultrastructure of complement-component-C4b-binding protein of human complement by synchrotron X-ray scattering and hydrodynamic analysis. Biochem J. 1986;233(3):799-807. (Pubitemid 16116154)
34. Castoldi E, Simioni P, Tormene D, Rosing J, Hackeng TM. Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma. J Thromb Haemost. 2010;8(2):294-300.
35. Wood JP, Ellery PE, Maroney SA, Mast AE. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol. 2014;34(1):169-176.
36. Van Wijnen M, Stam JG, Chang GT, et al. Characterization of mini-protein S, a recombinant variant of protein S that lacks the sex hormone binding globulin-like domain. Biochem J. 1998;330(Pt 1):389-396. (Pubitemid 28075766)
37. Villoutreix BO, Dahlbäck B, Borgel D, Gandrille S, Muller YA. Three-dimensional model of the SHBG-like region of anticoagulant protein S: new structure-function insights. Proteins. 2001;43(2):203-216.
38. Giri TK, Linse S, García de Frutos P, Yamazaki T, Villoutreix BO, Dahlbäck B. Structural requirements of anticoagulant protein S for its binding to the complement regulator C4b-binding protein. J Biol Chem. 2002;277(17):15099-15106. (Pubitemid 34952588)
39. Evenäs P, García De Frutos P, Linse S, Dahlbäck B. Both G-type domains of protein S are required for the high-affinity interaction with C4b-binding protein. Eur J Biochem. 1999;266(3):935-942.
40. Valentin S, Schousboe I. Factor Xa enhances the binding of tissue factor pathway inhibitor to acidic phospholipids. Thromb Haemost. 1996;75(5):796-800. (Pubitemid 26181856)
41. Willems GM, Janssen MP, Salemink I, Wun TC, Lindhout T. Transient high affinity binding of tissue factor pathway inhibitor-factor Xa complexes to negatively charged phospholipid membranes. Biochemistry. 1998;37(10):3321-3328. (Pubitemid 28125559)
42. Mine S, Yamazaki T, Miyata T, Hara S, Kato H. Structural mechanism for heparin-binding of the third Kunitz domain of human tissue factor pathway inhibitor. Biochemistry. 2002;41(1):78-85. (Pubitemid 34049383)